Association of the Epstein-Barr virus with hematolymphoid neoplasia

Advances in Anatomic Pathology

Volumn 3, Issue 1, 1996, Pages 1-15

  Weiss, Lawrence M ^a   Chang, Karen L ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002630448     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-199601000-00001     Document Type: Article

References (194)

1. Sample J, Young L, Martin B., Chatman T, Kieff E, Rickinson A. Epstein-Barr virus types 1 and 2 differ in the EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990; 64: 4084-92.
2. Sixbey JW, Chesney PJ, Resnick L, Shirley P., Buntin DM. Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989; 2: 761-5.
3. Sculley TB. Apollini A, Hurren L, Moss DE, Cooper D. Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 1990; 162: 643-8.
4. Nemerow GR, Cooper NR. CR2 (CD21) mediated infection of B lymphocytes of Epstein-Barr virus. Semin Virol 1992; 3: 117-24.
5. Tsoukas CD, Lambris JD. Expression of EBV/C3d receptors on T cells: biological significance. Immunol Today 1993; 14: 56-9.
6. Henderson S, Rowe M, Gregory C., et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein I protects infected B cells from programmed cell death. Cell 1991; 65: 1107-15.
7. Anagnostopoulos I, Hummel M, Kreschel C., Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 1995; 85: 744-50.
8. Weiss LM. Movahed LA. In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations. Am J Pathol 1989; 134: 651-9.
9. Deamant FD, Albujar PF, Chen Y-Y, Weiss LM. Epstein-Barr virus distribution in non-neoplastic lymph nodes. Mod Pathol 1993; 6: 729-32.
10. Gulley ML, Raab-Traub N. Detection of Epstein-Barr virus in human tissues by molecular genetic techniques. Arch Pathol Lab Med 1993; 117: 1115-20.
11. Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 1994; 145: 239-52.
12. Katz BZ, Raab-Traub N, Miller G. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis 1989; 160: 589-98.
13. Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986, 47: 883-9.
14. Montone KT. Friedman H, Hodinka RL, Hicks DG, Kant JA, Tomaszewski JE. In situ hybridization for Epstein-Barr virus Notl repeats in posttransplant lymphoproliferative disorder. Mod Pathol 1992; 5: 292-302.
15. Brousset P, Butet V, Chittal S., Selves J, Delsol G. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohisto-chemical correlation with anti-latent membrane protein antigen. Lab Invest 1992; 67: 457-64.
16. Chang KL, Chen Y-Y, Shibata D, Weiss LM. In situ hybridization methodology for the detection of EBV EBER-1 RNA in paraffin-embedded tissues, as applied to normal and neoplastic tissues. Diag Mol Pathol 1992; 1: 246-55.
17. Hamilton-Dutoit SJ. Pallesen G. Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization. Histopathology 1994; 25: 101-11.
18. Murray PG, Young LS, Rowe M, Crocker J. Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease. J Pathol 1992; 166: 1-5.
19. Grasser FA, Murray PG, Kremmer E, et al. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA 1); immunohistologic detection of EBNA 1 in the malignant cells of Hodgkin's disease. Blood 1994; 84: 3792-8.
20. Hummel M, Anagnostopoulos I. Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types J Pathol 1995; 175: 263-71.
21. Weiss LM, Gaffey MJ, Chen Y-Y, Frierson HF. Frequency of Epstein-Barr viral DNA in "Western" sinonasal and Waldeyer's ring lymphoma. Am J Surg Pathol 1992; 16: 156-62.
22. Hui PK, Tokunaga M, Chan W.Y., Ng CS, Chow J, Lee JCK. Ep-stein-Barr virus-associated gastric lymphoma in Hong Kong Chinese. Hum Pathol 1994; 25: 947-52.
23. Guinee D, Jaffe E, Kingma D., et al. Pulmonary lymphomatoid granulomatosis: evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol 1994; 18: 753-64.
24. Fukayama M, Ibuka T, Hayashi Y., Ooba T, Koike M, Mizutani S. Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol 1993; 143: 1044-9.
25. Martin A, Capron F, Liguory-Braunaud M-D, Frejacques C, Pluot M, Diebold J. Epstein-Barr virus-associated primary malignant lymphomas of the pleural cavity occurring in longstanding pleural chronic inflammation. Hum Pathol 1994; 25: 1314-8.
26. Sasajima Y, Yamabe H, Kobashi Y., Hirai K, Mori S. High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas. Am J Pathol 1993; 143: 1280-5.
27. Chang KL, Flaris N, Hickey W.F., Johnson RM, Meyer P, Weiss LM. Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus. Mod Pathol 1993; 6: 427-32.
28. Chang KL, Chen Y-Y, Weiss LM. Lack of evidence of Epstein-Barr virus in hairy cell leukemia and monocytoid B-cell lymphoma. Hum Pathol 1993; 24: 58-61.
29. Momose H, Jaffe ES, Shin S.S., Chen YY, Weiss LM. Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am J Surg Pathol 1992; 16: 859-67.
30. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lym-phoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702-3.
31. Lenoir GM, Philip T, Sohier R. Burkitt-type lymphoma: EBV association and cytogenetic markers in cases from various geographic locations. In: Magrath I, O'ConorGT, Ramot B, eds. Pathogenesis of leukemias and hmphomas: environmental influences. New York: Raven Press, 1984: 283.
32. Anwar N, Kingma DW. Bloch AR, et al. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphomas from Egypt: epidemiological correlations. Cancer Mol Biol 1994; 1: 213-22.
33. Shiramizu B, Barriga F, Neequaye J., et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991; 77: 1516-26.
34. Drut RM, Day S, Drut R., Meisner L. Demonstration of Epstein-Barr viral DNA in paraffin-embedded tissues of Burkitt's lymphoma from Argentina using the polymerase chain reaction and in situ hybridization. Pediatr Pathol 1994: 14: 101-9.
35. Bacchi MM, Bacchi CE, Alvarenga M, Miranda R., Chen Y-Y, Weiss LM. Burkitt's lymphoma in Brazil: strong association with Epstein-Barr virus. Mod Pathol 1995; 8: in press.
36. Gutierrez MI, Bhatia K, Barriga F., et al. Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 1992: 79: 3261.
37. Chan JKC, Tsang WYW, Ng CS, Wong CSC, Lo ESF. A study of the association of Epstein-Barr virus with Burkitt's lymphoma occurring in a Chinese population. Histopathology 1995; 26: 239-45.
38. Neri A, Barriga F, Inghirami G., et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and AIDS-associated lymphoma. Blood 1991; 77: 1092-5.
39. Birx D, Redfield RR, Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS related disorders. N Engl J Med 1986; 14: 874-9.
40. Arber DA, Shibata D, Chen Y-Y, Weiss LM. Characterization of the topography of Epstein-Barr virus infection in human immunodeficiency virus-associated lymphoid tissues. Mod Pathol 1992: 5: 559-66.
41. Shibata D, Weiss LM, Nathwani B.N., Brynes RK, Levine AM. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 1991; 77: 1527-33.
42. Hamilton-Dutoit S.J., Raphael M, Audouin J., et al. In situ demonstration of Epstein-Barr virus small RNAs (EBER1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 1993; 82: 619-24.
43. Shibata D. Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 1993; 81: 2102-9.
44. Schlaifer D, Brousset P, Attal M., et al. bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma. Histopathology 1994; 25: 77-82.
45. Pederson C, Gerstoft J, Lundgren J.D., et al. HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer 1991; 27: 1416-23.
46. Borisch B, Finke J, Hennig I., et al. Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients. J Pathol 1992; 168: 229-36.
47. Raphael MM, Audouin J, Lamine M., et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic feature in 36 cases. Am J Clin Pathol 1994; 101: 773-82.
48. Carbone A, Gloghini A, Zanette I., Canal B, Volpe R. Demonstration of Epstein-Barr viral genomes by in situ hybridization in acquired immunodeficiency syndrome-related high grade and anaplastic large cell CD30+ lymphomas. Am J Clin Pathol 1993; 99: 289-97.
49. MacMahon E, Glass J, Hayward S., et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991; 338: 969-73.
50. Pelicci PG, Knowles DM, Arlin Z, et al. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immunodeficiency syndrome-related lymphoproliferative disorders: implications for lymphomagenesis. J Exp Med 1986; 164: 2049-60.
51. Herndier BG, Shiramizu BT, McGrath MS. AIDS associated non-Hodgkin's lymphomas represent a broad spectrum of monoclonal and polyclonal lymphoproliferative processes. Curr Top Microbiol Immunol 1992; 182: 385-94.
52. Hamilton-Dutoit S.J., Rea D, Raphael M., et al. Epstein-Barr viruslatent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma: correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 1993; 143: 1072-85.
53. Brousset P, Drouet E, Schlaifer D., et al. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV. AIDS 1994; 8: 583-90.
54. Cesarman E, Chang Y, Moore P.S., Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995: 332: 1186-91.
55. Randhawa PS, Jaffe R, Demetris A.J., et al. The systemic distribution of Epstein-Barr virus genomes in fatal posttransplant lymphoproliferative disorders: an in situ hybridization study. Am J Pathol 1991; 138: 1027-33.
56. Cleary ML, Nalesnik MA. Shearer WT, Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988; 72: 349-52.
57. Knowles DM, Cesarman E, Chadburn A., et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995; 85: 552-65.
58. Kyaw MT, Hurren L, Evans L., et al. Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res 1992; 8: 1869-74.
59. Frank D, Cesarman E, Liu Y.F., Michler RE, Knowles DM. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 1995; 85: 1396-403.
60. Delecluse H-J, Kremmer E., Rouault J-P, Cour C, Bornkamm G, Berger F. The expression of Epstein-Barr virus latent proteins is related to the pathological feature of post-transplant lymphoproliferative disorders. Am J Pathol 1995; 146: 1113-20.
61. Young L, Alfieri C, Hennessy K., et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989; 321: 1080-5.
62. Kaplan MA, Ferry JA, Harris N.L., Jacobson JO. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers. Am J Clin Pathol 1994; 101: 590-6.
63. Patton DF, Wilkowski CW, Hanson C.A., et al. Epstein-Barr virus-determined clonality in posttransplant lymphoproliferative disease. Transplantation 1990; 49: 1080-4.
64. Randhawa P, Jaffe R, Demetris A.J., et al. Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens with post-transplant lymphoproliferative disease. N Engl J Med 1992; 327: 710-4.
65. Kamel OW, van de Rijn M, Le Brun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoproliferative lesions in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994; 25: 638-43.
66. Kamel OW, van de Rijn M, Weiss LM, et al. Reversible EBV-associated lymphomas occurring in the setting of methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993; 328: 1317-21.
67. Filipovich AH, Mathus A. Karnat D, Shapiro RS. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992; 52(suppl): 5465s-7s.
68. Spector BD, Perry GS, Kersey JH. Genetically determined immunodeficiency disease (GDID) and malignancy: report from the Immunodeficiency-Cancer Registry. Clin Immunol Immunopathol 1989; 11: 12-29.
69. Sander CA, Medeiros LM, Weiss L.M., Yano T., Sneller MC, Jaffe ES. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 1992; 16: 1170-82.
70. Grierson H. Purtilo DT. Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 1987; 106: 548.
71. Hamilton-Dutoit S., Pallesen G. A survey Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T cell lymphomas. Am J Pathol 1992; 140: 1315-25.
72. Harabuchi Y, Yamanaka N. Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphoma in patients with lethal midline granuloma. Lancet 1990; 335: 128-30.
73. Su I-J, Hsieh H-C, Lin K-H, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 1991; 77: 799-808.
74. Chan JKC, Yip TTC, Tsang WYW, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994; 18: 938-46.
75. van Gorp J., Weiping L, Jacobse K., et al. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China. J Pathol 1994: 173: 81-7.
76. Jones J, Shurin S, Abramowsky C., et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988; 318: 733-41.
77. Mishima K, Horiuchi K, Kojya S., Takahashi H, Ohsawa M, Aozasa K. Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. Cancer 1994; 73: 3041-6.
78. Arber DA, Weiss LM, Albujar P.F., Chen Y-Y, Jaffe ES. Nasal lymphomas in Peru: high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993; 17: 659-65.
79. Strickler JG, Meneses M, Habermann T.M., et al. "Polymorphic reticulosis": a reappraisal. Hum Pathol 1994; 25: 659-65.
80. Minarovits J, Hu L-F, Imai S, et al. Clonality, expression and meth-ylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J Gen Virol 1994; 75: 77-84.
81. Kanavaros P, Lescs M-C, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688-95.
82. Medeiros LJ, Peiper SC, Elwood L, Yano T., Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol 1991; 22: 1150-7.
83. Medeiros LJ, Jaffe ES, Chen Y-Y, Weiss LM. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol 1992; 16: 439-47.
84. Borisch B, Hennig I, Laeng R.H., Waelti ER, Kraft R, Laissue J. Association of the subtype 2 and the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993; 82: 858-64.
85. Tsang WYW, Chan JKC, Yip TTC, et al. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphoma. Hum Pathol 1994; 25: 758-65.
86. Su IJ, Hsu YH, Lin M.T., Cheng AL, Wang CH, Weiss LM. Epstein-Barr containing T cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 1993; 72: 2019-27.
87. Tokunaga M, Imai S, Uemura Y., Tokudome T, Osato T, Sato E. Epstein-Barr virus in adult T-cell leukemia/lymphoma. Am J Pathol 1993; 1993: 1263-9.
88. Kumar S, Kumar D, Kingma D.W., Jaffe ES. Epstein-Barr virus-associated T-cell lymphoma in a renal transplant patient. Am J Surg Pathol 1993; 17: 1046-53.
89. Kerschmann RL. Berger TG, Weiss LM, et al. Cutaneous lymphoma in human immunodeficiency virus disease: predominance of T-cell lineage with two clinicopathologic presentations. Arch Dermatol 1995; in press.
90. Korbjuhn P, Anagnostopoulos I, Hummel M., et al. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in HIV-negative European peripheral pleomorphic T-cell lymphomas. Blood 1993; 82: 217-23.
91. Bruin PCD. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positivity and clinical course. Histopathology 1993; 23: 509-18.
92. Zhou XG, Hamilton-Dutoit SJ, Yan Q.H., Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 1994; 24: 115-22.
93. Knecht H, Sahili R, Shaw P. Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy. Br J Hematol 1990; 75: 610-14.
94. Kon S, Sato T, Onodera K., et al. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma. Pathol Res Pract 1993; 189: 1137-44.
95. Weiss LM, Jaffe ES, Liu X, Chen Y-Y, Shibata D, Medeiros L. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymph-adenopathy-like lymphomas. Blood 1992; 79: 1789-95.
96. Borisch B. Caioni M, Hurwitz N, et al. Epstein-Barr virus subtype distribution in angioimmunoblastic lymphadenopathy. Int J Cancer 1993; 55: 748-52.
97. Anagnostopoulos I, Hummel M, Finn T., et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1992; 80: 1804-12.
98. Abruzzo LV, Schmidt K, Weiss L.M., et al. B cell lymphoma evolving from AILD: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood 1993; 82: 241-6.
99. Knecht H. Martius F. Bachmann E, et al. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia 1995; 9: 458-65.
100. Anagnostopoulos I, Hummel M, Tiemann M., Korbjuhn P, Parwaresch MR, Stein H. Frequent presence of latent Epstein-Barr virus infection in lymphoepithelioid cell lymphoma (Lennert's lymphoma). Histopathology 1994; 331-7.
101. Herbst H, Dallenbach F, Hummel M., et al. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. Blood 1991; 78: 2666-73.
102. Kanavaros P, Jiwa NM. Bruin PCD, et al. High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas. J Pathol 1992; 168: 307-15.
103. Lopategui JR. Gaffey MJ, Chan JKC, et al. Infrequent association of Epstein-Barr virus with CD30 positive anaplastic large cell lymphomas from American and Asian patients. Am J Surg Pathol 1995; 19: 42-9.
104. Brousset P, Rochaix P, Chittal S., Rubie H, Robert A, Delsol G. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993; 23: 189-91.
105. Anagnostopoulos I, Herbst H, Niedobitek G., Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989; 74: 810-6.
106. Ross CA, Schlegelmilch JA, Grogan T.M., Weiss LM, Schnitzer B, Hanson CA. Detection of Epstein-Barr virus genome in Ki-1 (CD-30)-positive, large cell anaplastic lymphoma. Am J Pathol 1992 141 457-65.
107. Dreno B, Celerier P, Fleischmann M., Bureau B, Litoux P. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sézary syndrome. Acta Derm Venereol 1994; 74: 355-7.
108. Peris K, Niedermeyer H, Cerroni L., Radaskiewicz T, Chimenti S, Hofler H. Detection of Epstein-Barr virus genome in primary cutaneous T and B cell lymphomas and psudolymphomas. Arch Dermatol Res 1994; 286: 364-8.
109. Bruin PCD, Jiwa M, Oudejans J.J., et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994; 83: 1612-8.
110. Kadin ME, Vonderheid EC, Weiss LM. Absence of Epstein-Barr viral expression in lymphomatoid papulosis. J Pathol 1993: 170: 145-8.
111. Harada H, Iwatsuki K, Kaneko F. Detection of Epstein-Barr virus genes in malignant lymphoma with clinical histologic features of cy-tophagic histiocytic panniculitis. J Am Acad Dermatol 1994: 31: 379-83.
112. Kawa-Ha K., Ishihara S, Ninomiya T. et al. CD3-negative lym-phoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989; 84: 51-5.
113. Gelb AB, van de Rijn M, Regula DP, et al. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol 1994; 25: 953-60.
114. Hart DNJ, Baker BW, Inglis M.J., et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992; 79: 2116-23.
115. Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease. N Engl J Med 1981; 304: 135-40.
116. Rosdahl N, Larsen S, Clemmesen J. Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience. Br Med J 1974; 2: 253-6.
117. Kvåle G., Høiby E, Pederson E. Hodgkin's disease in patients with previous infectious mononucleosis. Int J Cancer 1979; 23: 593-7.
118. Henle W, Henle G. Epstein-Barr virus-related serology in Hodgkin's disease. Natl Cancer Inst Monogr 1973; 36: 79-84.
119. Evans AS, Gutensohn NM. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Int J Cancer 1984; 34: 149-57.
120. Mueller N, Evans A, Harris N.L., et al. Hodgkin's disease and Epstein-Barr virus: altered antibody pattern before diagnosis. N Engl J Med 1989; 320: 689-92.
121. Weiss LM, Strickler JG, Warnke R.A., Purtilo DT, Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 1987; 129: 86-91.
122. Weiss LM, Movahed LA, Warnke R.A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320: 502-6.
123. Staal SP, Ambinder R. Beschorner WE, Hayward GS, Mann R. A survey of Epstein-Barr virus DNA in lymphoid tissue: frequent detection in Hodgkin's disease. Am J Clin Pathol 1989; 91: 1-5.
124. Libetta CM, Pringle JH, Angel C.A., Craft AW, Malcolm AJ, Lauder I. Demonstration of Epstein-Barr viral DNA in formalin-fixed paraffin-embedded samples of Hodgkin's disease. J Pathol 1990: 161: 255-60.
125. Jarrett RF, Gallagher A, Jones D.B., et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol 1991; 44: 844-8.
126. Gledhill S, Gallagher A, Jones D.B., et al. Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples. Br J Cancer 1991; 64: 227-32.
127. Brousset P, Chittal S, Schlaifer D., et al. Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeXl sections. Blood 1991; 77: 1781-6.
128. Coates PJ, Slavin G, d'Adrenne AJ. Persistence of Epstein-Barr virus in Reed-Sternberg cells throughout the course of Hodgkin's disease. J Pathol 1991; 164: 291-7.
129. Uhara H, Sato Y, Mukai K., et al. Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization. Jpn J Cancer Res 1990; 81: 272-8.
130. Roth J, Daus H, Gause A., Trumper L, Pfreundschuh M. Detection of Epstein-Barr virus DNA in Hodgkin- and Reed-Sternberg-cells by single cell PCR. Leuk Lymphoma 1994; 13: 137-42.
131. Gulley ML, Eagan PA, Quintanilla-Martinez L, et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity. Blood 1994; 83: 1595-602.
132. Delsol G, Meggetto F, Brousset P., et al. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen. Am J Pathol 1993; 142: 1729-38.
133. Weiss LM, Chen Y-Y, Liu X-F, Shibata D. Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139: 1259-65.
134. Lauritzen AF, Hording U, Nielsen HW. Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study. AMPIS 1994; 102: 495-500.
135. Khan G, Coates PJ, Gupta R.K., Kangro HO, Slavin G. Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells. Am J Pathol 1992; 140: 757-62.
136. Herbst H, Steinbrecher E, Niedobitek G., et al. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 1992: 80: 484.
137. Wu TC, Mann RB, Charache P, et al. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer 1990; 46: 801-4.
138. Jiwa NM, Kanavaros P, Bruin PCD, et al. Presence of Epstein-Barr virus harbouring small and intermediate-sized cells in Hodgkin's disease. Is there a relationship with Reed-Sternberg cells? J Pathol 1993; 170: 129-36.
139. Zhou X-G, Hamilton-Dutoit SJ, Yan Q-H, Pallesen G. The association between Epstein-Barr virus and Chinese Hodgkin's disease. Int J Cancer 1993; 55: 359-63.
140. Hummel M, Anagnostopoulos I, Dallenbach F., Korbjuhn P, Dimmler C, Stein H. EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol 1992; 82: 689-94.
141. Bellas C, Mampaso F, Fraile F., Molina A, Bricio T, Cuesta C. Detection of Epstein-Barr genome in the lymph nodes of Hodgkin's disease. Postgrad Med J 1993; 69: 916-9.
142. Herbst H, Niedobitek G, Kneba M. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol 1990; 137: 13-8.
143. Bignon YJ, Bernard D, Cure H., et al. Detection of Epstein-Barr viral genomes in lymph nodes of Hodgkin's disease patients. Mol Carcinogenesis 1990; 3: 9-11.
144. Knecht H, Odermatt BF, Bachmann E, et al. Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without genomic evidence of B- or T-cell clonality. Blood 1991; 78: 760-7.
145. Shibata D, Hansmann ML, Weiss L.M., Nathwani BN. Epstein-Barr virus infections and Hodgkin's disease: a study of fixed tissues using the polymerase chain reaction. Hum Pathol 1991; 22: 1262-7.
146. Wright C, Reid A, Tsai M., et al. Detection of Epstein-Barr virus sequences in Hodgkin's disease by the polymerase chain reaction. Am J Pathol 1991; 139: 393-8.
147. Masih A, Weisenburger D, Duggan M., et al. Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells. Am J Pathol 1991; 139: 37-43.
148. Fellbaum C, Hansmann M-L, Niedermeyer H. Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease. Am J Clin Pathol 1992; 98: 319-23.
149. Armstrong AA, Weiss LM, Gallagher A, et al. Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease. Leukemia 1992; 6: 869-74.
150. Gledhill S, Gallagher A, Jones D.B., et al. Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus in tumour samples. Br J Cancer 1991; 64: 227-32.
151. Lin JC, Lin SC, De B.K., Chan WP, Evatt BL. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Blood 1993; 81: 3372-81.
152. Poppema S, van Imhoff G, Torensma R, Smit J. Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection. Am J Clin Pathol 1985; 84: 385-90.
153. Pallesen G, Hamilton-Dutoit SJ, Rowe M., Young S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320-2.
154. Herbst H, Dallenbach F, Hummel M., et al. Epstein-Barr virus latent membrane protein expression in Hodgkin's and Reed-Sternberg cells. Proc Natl Acad Sci USA 1991; 88: 4766-70.
155. Delsol G, Brousset P, Chittal S., Rigal HF. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated Bam HI-W probes in Hodgkin's disease. Am J Pathol 1992; 140: 247-53.
156. Kaczorowski S, Kaczorowska M, Christensson B. Expression of EBV encoded latent membrane protein 1 and bcl-2 protein in childhood and adult Hodgkin's disease: application of microwave irradiation for antigen retrieval. Leuk Lymphoma 1994: 273-83.
157. Pinkus GS, Lones M, Shintaku I.P., Said JW. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease. Mod Pathol 1994; 7: 454-61.
158. Deacon EM, Pallesen G, Niedobitek G., et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993; 177: 339-49.
159. Knecht H, Bachmann E, Joske DJL, et al. Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia 1993; 7: 580-5.
160. Knecht H. Bachmann E, Brousset P, et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937-42.
161. Chen ML, Tsai CN, Liang C.L., et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992; 7: 2131-40.
162. Deacon EM, Pallesen G. Niedobitek G, et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993; 177: 339-49.
163. Pallesen G, Sandvej K, Hamilton-Dutoit SJ, Rowe M., Young LS. Activation of Epstein-Barr virus replication in Hodgkin's and Reed-Sternberg cells. Blood 1991; 78: 1162-5.
164. Uccini S, Monardo F, Stoppacciaro A., et al. High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. Int J Cancer 1990: 46: 581.
165. Bibeau F, Brousset P, Knecht H., et al. Epstein-Barr virus replication in Hodgkin's disease. Bull Cancer 1994; 81: 114-88.
166. Vasef MA, Kamel OW, Chen Y-Y. Medeiros LJ, Weiss LM. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 1995; in press.
167. Boiocchi M, Dolcetti R, Re V.D., Gloghini A., Carbone A. Demonstration of
168. Brousset P, Schlaifer D, Meggetto F., et al. Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease. Blood 1994; 84: 2447-51.
169. Stoler MH, Nichols GE, Symbula M, Weiss LM. Nodular L&H lymphocyte predominance Hodgkin's disease: evidence for a kappa light chain-restricted monotypic B cell neoplasm. Am J Pathol 1995; 146: 812-8.
170. Armstrong AA, Alexander FE, Paes R.P., et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993; 142: 1683-8.
171. Ambinder RF, Browning PJ, Lorenzana I, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993: 81: 496.
172. Mack TM, Cozen W, Shibata DK. et al. Concordance in identical twins suggests genetic susceptibility to young adult Hodgkin's disease. N Engl J Med 1994; 332: 413-8.
173. Schlaifer D, Rigal-Huguet F, Robert A. et al. Epstein-Barr virus in familial Hodgkin's disease. Br J Haematol 1994; 88: 636-8.
174. Levine PH, Pallesen G, Ebbesen P, Harris N, Evans AS, Mueller N. Evaluation of Epstein-Barr virus antibody patterns and detection of viral markers in the biopsies of patients with Hodgkin's disease. Int J Cancer 1994; 59: 48-50.
175. Lennette ET, Rymo L, Yadav M., et al. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA1, EBNA2 and EBNA6. Eur J Cancer 1993; 11: 1584-9.
176. Vestlev PM, Pallesen G, Sandvej K., Hamilton-Dutoit SJ, Bendtzen SM. Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane antigen. Int J Cancer 1991; 50: 670-1.
177. Armstrong AA, Lennard A, Alexander F.E., et al. Prognostic significance of Epstein-Barr virus association in Hodgkin's disease [Letter]. Eur J Cancer 1994; 30A: 1045-6.
178. O'Grady J., Stewart S, Elton R.A., Krajewski AS. Epstein-Barr virus in Hodgkin's disease and site of origin of tumour. Lancet 1994; 343: 265-6.
179. Kingma DW, Medeiros LJ, Barletta J, et al. Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol 1994; 18: 48-61.
180. Hansmann ML, Shibata D, Lorenzen J., Hell K, Nathwani BN, Fischer R. Incidence of Epstein-Barr virus, bcl-2 expression and chromosomal translocation t(14; 18) in large cell lymphoma associated with paragranuloma (lymphocyte-predominant Hodgkin's disease). Hum Pathol 1994; 25: 240-3.
181. Poppema S. Epstein-Barr virus positivity in Hodgkin's disease does not correlate with an HLA A2-negative phenotype. Cancer 1994; 73: 3059-63.
182. Armstrong AA, Gallagher A, Krajewski A.S., et al. The expression of the EBV latent membrane protein (LMP-1) is independent of CD23 and bcl-2 in Reed-Sternberg cells in Hodgkin's disease. Histopathol-ogy 1992; 21: 72-3.
183. Foss HD, Herbst H, Oelmann E., et al. Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol 1993; 84: 627-35.
184. Niedobitek G, Rowlands DC, Young L.S., et al. Overexpression of p53 in Hodgkin's disease: lack of correlation with Epstein-Barr virus infection. J Pathol 1993; 169: 207-12.
185. Bai MC, Jiwa NM. Horstman A, et al. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease. J Pathol 1994; 174: 49-55.
186. Khan G, Gupta RK, Coates P.J., Slavin G. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease. Am J Pathol 1993; 143: 1270-4.
187. Bhagat SK, Medeiros LJ, Weiss L.M., Wang J., Raffeid M, Stetler-Stevenson M. bcl-2 expression in Hodgkin's disease. Correlation with the t(14; 18) translocation and Epstein-Barr virus. Am J Clin Pathol 1993; 99: 604.
188. LeBrun DP, Ngan BY, Weiss L.M., Huie P., Warnke RA, Cleary ML. The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma. Blood 1994; 83: 223-30.
189. Chan JKC, Yip TTC, Tsang WYW, Lau W-H, Wong CSC, Ma VWS. Detection of Epstein-Barr virus in Hodgkin's disease occurring in an Oriental population. Hum Pathol 1995; 26: 314-8.
190. Chang KL, Albujar PF, Chen Y.Y., Johnson RM, Weiss LM. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 1993; 81: 496-502.
191. Herndier BG, Sanchez HC, Chang K.L., Chen YY, Weiss LM. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. Am J Pathol 1993; 142: 1073-9.
192. Boyle MJ, Vasak E, Tschuchnigg M., et al. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood 1993; 81: 468-74.
193. Re VD, Boiocchi M, Vita S.D., et al. Subtypes of Epstein-Barr virus in HIV-associated and HIV-unrelated Hodgkin's disease cases. Int J Cancer 1993; 54: 895-8.
194. Rubin D, Hudnall SD. Aisenberg A, Jacobson JO, Harris NL. Rich-ter's transformation of chronic lymphocytic leukemia with Hodg-kin's-like cells is associated with Epstein-Barr virus infection. Mod Pathol 1994; 7: 91-8.